Atlas Trials

A Phase I Study of LY-CovMab Injection in Chinese Healthy Subjects

Clinical trial NCT04973735 · UNKNOWN

Trial details

NCT number
NCT04973735
Sponsor
Luye Pharma Group Ltd.
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Covid19
Start date
2020-11-10
Primary completion
2021-05-01
Enrollment
42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.